Cargando…

(99m)Tc-sestamibi SPECT/CT and (18)F-FDG-PET/CT have similar performance but different imaging patterns in newly diagnosed multiple myeloma

(18)F-fluorodeoxiglucose ((18)F-FDG)-PET/CT has been widely used to evaluate multiple myeloma. (99m)Tc-sestamibi (MIBI) scintigraphy has also been proposed for assessing multiple myeloma, but its use with state-of-the-art single-photon emission computed tomography/computed tomography (SPECT/CT) tech...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mosci, Camila, Pericole, Fernando V., Oliveira, Gislaine B., Delamain, Marcia T., Takahashi, Maria E.S., Carvalheira, José Barreto C., Etchebehere, Elba C.S.C., Santos, Allan O., Miranda, Eliana C. M., Lima, Mariana C.L., Amorim, Barbara J., de Souza, Carmino A., Lorand-Metze, Irene, Ramos, Celso D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7497601/ https://www.ncbi.nlm.nih.gov/pubmed/32732603 http://dx.doi.org/10.1097/MNM.0000000000001259

Ejemplares similares

SPECT/CT with (99m)Tc-sestamibi for the evaluation of skeletal muscle perfusion after electrical muscle stimulation in athletes
por: Birelli, Beatriz, et al.
Publicado: (2019)

Ectopic Submandibular Parathyroid Adenoma by Tc-99m Sestamibi SPECT/CT Localization
por: Ng, Fung Him, et al.
Publicado: (2020)

Utility of (99m)Tc-Sestamibi SPECT/CT in the Early Localization of Metastatic Parathyroid Carcinoma
por: Fernando, Patrick Earl A, et al.
Publicado: (2018)

Is dual-phase SPECT/CT with (99m)Tc-sestamibi better than single-phase SPECT/CT for lesion localization in patients with hyperparathyroidism?
por: Lee, Suk Hyun, et al.
Publicado: (2020)

Systematic evaluation of (99m)Tc-tetrofosmin versus (99m)Tc-sestamibi to study murine myocardial perfusion in small animal SPECT/CT
por: Vrachimis, Alexis, et al.
Publicado: (2012)

Case Report: Multivessel Coronary Disease Assessment with SPECT (99m)Tc-Sestamibi and Rubidium-82 PET/CT
por: Padilha, Bruno Gomes, et al.
Publicado: (2017)

(99m)Tc-Sestamibi/(123)I Subtraction SPECT/CT in Parathyroid Scintigraphy: Is Additional Pinhole Imaging Useful?
por: Tunninen, Virpi, et al.
Publicado: (2017)

Use of (99m)Tc‐sestamibi SPECT/CT for indeterminate renal tumours: a pilot diagnostic accuracy study
por: Warren, Hannah, et al.
Publicado: (2022)

Personalization of (99m)Tc-sestamibi activity in SPECT/CT myocardial perfusion imaging with the cardiofocal SmartZoom® collimator
por: Verrecchia-Ramos, Emilie, et al.
Publicado: (2023)

The role of (18)F-FCH PET/CT in patients with uremic hyperparathyroidism compared with (99m)Tc-sestaMIBI SPECT/CT and ultrasonography
por: Xue, Yu, et al.
Publicado: (2019)

Proposal for a Quantitative (18)F-FDG PET/CT Metabolic Parameter to Assess the Intensity of Bone Involvement in Multiple Myeloma
por: Takahashi, Maria E. S., et al.
Publicado: (2019)

Reverse perfusion pattern in myocardial spect with 99mTc-SestaMIBI
por: Schillaci, O, et al.
Publicado: (2013)

Preoperative nodal staging of non-small cell lung cancer using (99m)Tc-sestamibi spect/ct imaging
por: Miziara, Juliana Muniz, et al.
Publicado: (2011)

Visual evaluation and differentiation of renal oncocytomas from renal cell carcinomas by means of (99m)Tc-sestamibi SPECT/CT
por: Tzortzakakis, Antonios, et al.
Publicado: (2017)

Combining contrast-enhanced ultrasound, CT perfusion and (99m)Tc-Sestamibi SPECT/CT to guide diagnosis in a case of solid renal tumour
por: Kalarakis, Georgios, et al.
Publicado: (2020)

Detection of anthracycline-induced cardiotoxicity using perfusion-corrected (99m)Tc sestamibi SPECT
por: Safee, Zaitulhusna M., et al.
Publicado: (2019)

The preoperative localisation of small parathyroid adenomas improves when adding Tc-99m-Sestamibi SPECT to multiphase contrast-enhanced CT
por: Sandqvist, Patricia, et al.
Publicado: (2021)

Machine Learning Integrating (99m)Tc Sestamibi SPECT/CT and Radiomics Data Achieves Optimal Characterization of Renal Oncocytic Tumors
por: Klontzas, Michail E., et al.
Publicado: (2023)

Optimization of SPECT/CT imaging protocols for quantitative and qualitative (99m)Tc SPECT
por: Kupitz, Dennis, et al.
Publicado: (2021)

Molecular Imaging Diagnosis of Renal Cancer Using (99m)Tc-Sestamibi SPECT/CT and Girentuximab PET-CT-Current Evidence and Future Development of Novel Techniques
por: Tataru, Octavian Sabin, et al.
Publicado: (2023)

Multiple endocrine neoplasia type 1 with anterior mediastinal parathyroid adenoma: successful localization using Tc-99m sestamibi SPECT/CT
por: Park, Hye Lim, et al.
Publicado: (2016)

Quantitative application of dual-phase 99mTc-sestamibi SPECT/CT imaging of parathyroid lesions: identification of optimal timing in secondary hyperparathyroidism
por: Wang, Yuhua, et al.
Publicado: (2023)

Initial In Vivo Quantification of Tc-99m Sestamibi Uptake as a Function of Tissue Type in Healthy Breasts Using Dedicated Breast SPECT-CT
por: Mann, Steve D., et al.
Publicado: (2012)

Comparison of Neck Ultrasonography, Dual Phase (99m)Tc-Sestamibi with early SPECT-CT & (18)F-Fluorocholine PET-CT as First Line Imaging in Patients with Primary Hyperparathyroidism
por: Abhishek, Behera, et al.
Publicado: (2023)

Tc-99m-PSMA-SPECT/CT Is Superior to Tc-99m-MDP-SPECT/CT in the Staging of Prostatic Cancer with Osseous Metastases after External Beam Radiotherapy
por: Liepe, Knut, et al.
Publicado: (2022)

[(99cm)Tc]Tc-PSMA-I&S-SPECT/CT: experience in prostate cancer imaging in an outpatient center
por: Werner, P., et al.
Publicado: (2020)

Fluorodeoxyglucose PET/CT and Tc99m-Sestamibi scan, dual tracer imaging in evaluation of osteonecrosis of jaw
por: Joshi, Prathamesh, et al.
Publicado: (2012)

(18)F-Fluorocholine PET/CT, Tc-99m-MIBI and TC-99m-MDP SPECT/CT in Tertiary Hyperparathyroidism with Renal Osteodystrophy
por: Ferrari, Cristina, et al.
Publicado: (2020)

Protocol for a MULTI-centre feasibility study to assess the use of (99m)Tc-sestaMIBI SPECT/CT in the diagnosis of kidney tumours (MULTI-MIBI study)
por: Warren, Hannah, et al.
Publicado: (2023)

Quantification of (99m)Tc-DPD concentration in the lumbar spine with SPECT/CT
por: Cachovan, Michal, et al.
Publicado: (2013)

(99m)Tc-Ethambutol Scan with SPECT/CT in Knee Joint Tuberculosis
por: Kalra, Simran, et al.
Publicado: (2022)

Quantitative (99m)Tc-DPD-SPECT/CT assessment of cardiac amyloidosis
por: Kessler, Lukas, et al.
Publicado: (2022)

(99m)Tc-Radiolabeled TPGS Nanomicelles Outperform (99m)Tc-Sestamibi as Breast Cancer Imaging Agent
por: Tesan, Fiorella C., et al.
Publicado: (2019)

Upfront F18-choline PET/CT versus Tc99m-sestaMIBI SPECT/CT guided surgery in primary hyperparathyroidism: the randomized phase III diagnostic trial APACH2
por: Quak, Elske, et al.
Publicado: (2021)

Diagnostic accuracy of [(99m)Tc]Tc-Sestamibi in the assessment of thyroid nodules
por: Yordanova, Anna, et al.
Publicado: (2017)

Comparison of LDPI to SPECT perfusion imaging using (99m)Tc-sestamibi and (99m)Tc-pyrophosphate in a murine ischemic hind limb model of neovascularization
por: Hendrikx, Geert, et al.
Publicado: (2016)

(90)Y SPECT/CT quantitative study and comparison of uptake with pretreatment (99 m)Tc‐MAA SPECT/CT in radiomicrosphere therapy
por: Debebe, Senait Aknaw, et al.
Publicado: (2019)

Computed tomography–based skeletal segmentation for quantitative PET metrics of bone involvement in multiple myeloma
por: Takahashi, Maria E.S., et al.
Publicado: (2020)

Utility of (99m)Tc-MDP SPECT-CT for the diagnosis of sesamoiditis as cause of metatarsalgia
por: Sharma, Punit, et al.
Publicado: (2012)

Efficacy of (99m)Tc-DTPA SPECT/CT in diagnosing Orbitopathy in graves’ disease
por: Szumowski, Piotr, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_0dbd86sa0puspt8c2ecqv1jinc